Evaluation of the Sentinel Immunized Node for Immune Monitoring of Cancer Vaccines-Reference-Cited by-同舟云学术

Evaluation of the Sentinel Immunized Node for Immune Monitoring of Cancer Vaccines

Published:2008-10-16 Issue:12 Volume:15 Page:3538-3549
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Slingluff Craig L.,Yamshchikov Galina V.,Hogan Kevin T.,Hibbitts Sarah C.,Petroni Gina R.,Bissonette Eric A.,Patterson James W.,Neese Patrice Y.,Grosh William W.,Chianese-Bullock Kimberly A.,Czarkowski Andrea,Rehm Patrice K.,Parekh Jayashree

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-008-0046-4.pdf

Reference37 articles.

1. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004; 10:909–15

2. Drake CG, Jaffee E, Pardoll DM. Mechanisms of immune evasion by tumors. Adv Immunol 2006; 90:51–81

3. Slingluff CL, Chianese-Bullock KA, Bullock TNJ, et al. Immunity to melanoma antigens: from self-tolerance to immunotherapy. Adv Immunol 2006; 90:243–95

4. Marchand M, van Baren N, Weynants P, et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999; 80:219–30

5. Coulie PG, Karanikas V, Colau D, et al. A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci USA 2001; 98:10290–5

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide emulsions in incomplete Freund’s adjuvant create effective nurseries promoting egress of systemic CD4⁺and CD8⁺T cells for immunotherapy of cancer;Journal for ImmunoTherapy of Cancer;2022-09

2. Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64);Journal for ImmunoTherapy of Cancer;2022-09

3. A nano-enhanced vaccine for metastatic melanoma immunotherapy;Cancer Drug Resistance;2022

4. A pilot trial of vaccination with Carcinoembryonic antigen and Her2/neu peptides in advanced colorectal cancer;International Journal of Cancer;2021-10-23

5. Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63);Journal for ImmunoTherapy of Cancer;2021-01